首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Slow Binding Inhibition and Mechanism of Resistance of Non-nucleoside Polymerase Inhibitors of Hepatitis C Virus
【2h】

Slow Binding Inhibition and Mechanism of Resistance of Non-nucleoside Polymerase Inhibitors of Hepatitis C Virus

机译:丙型肝炎病毒的慢结合抑制和非核苷聚合酶抑制剂的耐药机制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The binding affinity of four palm and thumb site representative non-nucleoside inhibitors (NNIs) of HCV polymerase NS5B to wild-type and resistant NS5B polymerase proteins was determined, and the influence of RNA binding on NNI binding affinity was investigated. NNIs with high binding affinity potently inhibited HCV RNA polymerase activity and replicon replication. Among the compounds tested, HCV-796 showed slow binding kinetics to NS5B. The binding affinity of HCV-796 to NS5B increased 27-fold over a 3-h incubation period with an equilibrium Kd of 71 ± 2 nm. Slow binding kinetics of HCV-796 was driven by slow dissociation from NS5B with a koff of 4.9 ± 0.5 × 10−4 s−1. NS5B bound a long, 378-nucleotide HCV RNA oligonucleotide with high affinity (Kd = 6.9 ± 0.3 nm), whereas the binding affinity was significantly lower for a short, 21-nucleotide RNA (Kd = 155.1 ± 16.2 nm). The formation of the NS5B-HCV RNA complex did not affect the slow binding kinetics profile and only slightly reduced NS5B binding affinity of HCV-796. The magnitude of reduction of NNI binding affinity for the NS5B proteins with various resistance mutations in the palm and thumb binding sites correlated well with resistance -fold shifts in NS5B polymerase activity and replicon assays. Co-crystal structures of NS5B-Con1 and NS5B-BK with HCV-796 revealed a deep hydrophobic binding pocket at the palm region of NS5B. HCV-796 interaction with the induced binding pocket on NS5B is consistent with slow binding kinetics and loss of binding affinity with mutations at amino acid position 316.
机译:确定了四种HCV聚合酶NS5B的手掌和拇指部位代表性非核苷抑制剂(NNIs)与野生型和耐药NS5B聚合酶蛋白的结合亲和力,并研究了RNA结合对NNI结合亲和力的影响。具有高结合亲和力的NNI可有效抑制HCV RNA聚合酶活性和复制子复制。在测试的化合物中,HCV-796与NS5B的结合动力学较慢。 HCV-796与NS5B的结合亲和力在3小时的孵育时间内增加了27倍,平衡Kd为71±2 nm。 HCV-796的缓慢结合动力学是由NS5B的缓慢解离驱动的,koff为4.9±0.5×10 -4 s -1 。 NS5B以高亲和力(Kd = 6.9±0.3 nm)结合长的378个核苷酸的HCV RNA寡核苷酸,而对于短的21个核苷酸的RNA(Kd = 155.1±16.2 nm),结合亲和力明显较低。 NS5B-HCV RNA复合物的形成不影响慢的结合动力学曲线,仅轻微降低了HCV-796的NS5B结合亲和力。在手掌和拇指结合位点具有各种抗性突变的NS5B蛋白的NNI结合亲和力降低的幅度与NS5B聚合酶活性和复制子分析的抗性倍数变化密切相关。 NS5B-Con1和NS5B-BK与HCV-796的共晶体结构在NS5B的手掌区域揭示了一个深层的疏水结合口袋。 HCV-796与NS5B上诱导的结合口袋的相互作用与缓慢的结合动力学以及氨基酸第316位突变引起的结合亲和力丧失相一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号